Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2017 / Oct / All Eyes on Biomarkers
Omics Clinical care Precision medicine Screening and monitoring Biochemistry and molecular biology Analytical science Molecular Pathology

All Eyes on Biomarkers

Could age-related macular degeneration be diagnosed through blood plasma analysis?

10/20/2017 1 min read

Share

It’s a classic “chicken and egg” scenario. When retinal diseases like age-related macular degeneration (AMD) strike, early diagnosis and intervention give the best prognosis and visual outcomes. But in reality, retinal disease cannot be diagnosed until structural changes are seen, and some patients only present at ophthalmology clinics when the visual symptoms – and the underlying pathology – are at an advanced stage. Now, a team from Massachusetts Eye and Ear Hospital, Boston, USA, are proposing that metabolomics analysis might hold the key to identifying those at risk during the early stages of disease diagnosis – or even before the disease starts to develop.

“Metabolomics has recently been shown to provide biologically informative markers of complex diseases, such as Alzheimer’s, so we decided to research the role of metabolomics in AMD to find biomarkers for diagnosis and prognosis in this disease,” says Deeba Husain, co-senior author on the corresponding paper (1). In the study, the team took blood plasma samples from 90 patients with AMD (30 each with early, intermediate and late stage disease) and from 120 patients with normal macular health. The samples were analyzed using ultra high-performance liquid chromatography coupled to tandem mass spectrometry. They found that a total of 87 metabolites, mostly from glycerophospholipid metabolism, differed significantly between patients with AMD and the controls. Of these, 48 were significantly different across the different stages of AMD. “We were surprised to find that glycerophospholipid metabolism specifically seems to have a strong association with AMD – this pathway was highly enriched among the significant metabolites (p=4.7 x 10-9),” says Husain, who believes the results could form the basis of the first blood biomarker for early diagnosis and prognosis of AMD. But their results aren’t just important for diagnosing disease. “The detection of very significant metabolite pathways could lead to finding a new druggable target for treatment,” says Husain. “And that could lay the path for personalized medicine in the management of AMD.”  Next steps for the team include a large multicenter study to validate their findings, as well as a long-term follow-up study to better define the role of glycerophospholipid metabolism in disease progression.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. I Laíns et al., “Human plasma metabolomics study across all stages of age-related macular degeneration identifies potential lipid biomarkers”, PLoS One, 12, e0177749 (2017). PMID: 28542375.

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Omics
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

“Pop” Goes the Sensor
Omics
“Pop” Goes the Sensor

January 19, 2022

1 min read

A new device could help scientists identify signs of arrhythmia, heart attack, and cardiac fibrosis

Improving Risk Stratification
Omics
Improving Risk Stratification

February 3, 2022

1 min read

Two genes have been identified that may be linked to prostate cancer outcomes

The Ultimate Vision for Rare Disease
Omics
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational pathology can take rare disease diagnostics to the next level

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.